Earnings Call · Q2 FY2026·2026-08-13

Q2 26EPS +100.00%*·Rev n/aQ1 26EPS 0.00%·Rev n/aQ4 25EPS +5.56%·Rev n/aQ3 25EPS -75.00%·Rev n/a⚠ consensus missing

Eton Pharmaceuticals, Inc. ETON

David Krempa — Chief Business Officer

Sean Brynjelsen — Chief Executive Officer

Judith Matthews — Chief Financial Officer

+44.3%1d on move date3d+55.5%5d+46.8%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ETON calls or request research access.

More ETON calls Browse calls Request research access